A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

samantha busch shows off incredible hair growth after battling alopecia areata, revealing resilience, treatments, and a ...

The study confirmed that ritlecitinib was well tolerated among participants, making it a potential candidate for systemic therapy in alopecia areata[2]. In addition to these specific treatments ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

Panelists discuss how switching therapies in patients with alopecia areata (AA) is often necessary when initial treatments ...

The global alopecia treatment market size was valued at USD 3.48 billion in 2024 and is projected to reach from USD 3.62 billion in 2025 to USD 5.20 billion by 2033, growing at a CAGR of 4.1% during ...

The risk for alopecia areata is increased among patients with lower serum levels of vitamin D and zinc, but no relationship was observed with copper.

Superficial cryotherapy is a novel cold-based treatment that has emerged as a potential therapy for patchy alopecia areata ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

According to a recent study, comorbid chronic inflammatory diseases (CIDs) influence the prognosis of alopecia areata (AA).

In modern medicine, alopecia treatment is essential since It reduces ... including androgenic alopecia, alopecia areata, alopecia totalis, and others. According to U.S. Census Bureau statistics ...